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ABSTRACT We propose a mathematical model for mitochondria-dependent apoptosis, in which kinetic cooperativity in
formation of the apoptosome is a key element ensuring bistability. We examine the role of Bax and Bcl-2 synthesis and
degradation rates, as well as the number of mitochondrial permeability transition pores (MPTPs), on the cell response to
apoptotic stimuli. Our analysis suggests that cooperative apoptosome formation is a mechanism for inducing bistability, much
more robust than that induced by other mechanisms, such as inhibition of caspase-3 by the inhibitor of apoptosis (IAP).
Simulations predict a pathological state in which cells will exhibit a monostable cell survival if Bax degradation rate is above a
threshold value, or if Bax expression rate is below a threshold value. Otherwise, cell death or survival occur depending on initial
caspase-3 levels. We show that high expression rates of Bcl-2 can counteract the effects of Bax. Our simulations also
demonstrate a monostable (pathological) apoptotic response if the number of MPTPs exceeds a threshold value. This study
supports our contention, based on mathematical modeling, that cooperativity in apoptosome formation is critically important
for determining the healthy responses to apoptotic stimuli, and helps deﬁne the roles of Bax, Bcl-2, and MPTP vis-a`-vis
apoptosome formation.
INTRODUCTION
The biochemical mechanism of apoptosis, or programmed
cell death (PCD), is an area of extensive study because of the
importance of maintaining the homeostatic balance in re-
sponse to pro- or antiapoptotic stimuli (1). The balance between
cell proliferation and apoptosis is indeed crucial for the
healthy functioning of organisms. Dysregulation of apopto-
sis is implicated in many degenerative and autoimmune
diseases, including cancer, acquired immune deﬁciency syn-
drome, neurodegenerative disorders, and viral and bacterial
infections (2).
Apoptosis may be triggered by extracellular death signals,
deprivation of survival signals, and genetic or toxicological
damage (3). A common observation in response to these
stimuli is the activation of caspases, a group of cysteine
proteases that serve as main effectors of PCD. There are two
major pathways of caspase activation: i), ligand-dependent
or receptor-induced activation (extrinsic pathway), through
death receptors such as Fas (CD95) or the members of tumor
necrosis factor receptor (TNF-R) superfamily, and ii),
mitochondria-dependent activation (intrinsic pathway), via
cytochrome c (cyt c) release from mitochondria induced by
stress, irradiation, or inﬂammation (4,5).
Binding of death ligands such as Fas ligand (FasL),
TNF, or tumor necrosis-related apoptosis-inducing ligand
(TRAIL) usually induces the oligomerization of the associ-
ated TNF-Rs, followed by recruitment of adaptor pro-
teins—Fas-associated death domain proteins (FADD)—to
the cytoplasmic portions of the receptors (6). The resulting
death inducing signaling complex (DISC) recruits multiple
procaspases-8 molecules that mutually cleave and activate
one another through induced proximity. In Type I cells,
activation of caspase-8 in large quantities leads to the activa-
tion of other caspases, including the executioner caspase-3
that ultimately leads to apoptosis. In Type II cells, the
amount of caspase-8 generated at the DISC is small, and the
activation cascade does not propagate directly but is instead
ampliﬁed via the mitochondria (Fig. 1). This process is
initiated by the cleavage of Bid by caspase-8, followed by
the translocation of the truncated Bid (tBid) to the mito-
chondria, which induces the release of proapoptotic mole-
cules such as cyt c and Smac/DIABLO to the cytoplasm (7).
Cyt c release closely depends on the opening of mitochon-
drial permeability transition pores (MPTPs).
The mitochondrial apoptotic pathway is largely mediated
through Bcl-2 family proteins, which include both proapop-
totic members such as Bax, Bak, and BNIP3 that promote
mitochondrial permeability, and antiapoptotic members such
as Bcl-2 and Bcl-xL that inhibit their effects, or inhibit the
mitochondrial release of cyt c (8). Another important com-
ponent is the tumor suppressor protein p53, which simulta-
neously suppresses Bcl-2 and activates Bax. Cyt c leakage
supports the formation of an apoptosome complex by binding
to apoptotic protease activating factor-1 (Apaf-1), which acti-
vates the caspase-9 molecules (upon cleavage of the bound
zymogen procaspases-9), which in turn activate caspase-3 (9).
Caspase-3 cleaves the inhibitor of caspase activated DNase
(ICAD), leading to DNA degradation or fragmentation (10),
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whereas the inhibitor of apoptosis (IAP) inhibits both caspase-3
and caspase-9 activities.
A recent study by Nair and co-workers (11) invites
attention to the occurrence of a bifurcation into two states,
favoring either cell death or cell survival, upon examination of
a population of cells undergoing oxidative stress. Essentially,
each cell is observed to activate either homeostatic or
apoptotic signals early after H2O2 exposure; eventually, the
stimuli that activate proapoptotic signals cause a given cell to
succumb to PCD in accord with an all-or-none activation of
the caspase cascade (12). The remaining cells, which undergo
activation of the extracellular regulated kinase (ERK) signal-
ing pathway at an early stage of oxidative stress, exhibit
cytoprotective responses. The observed bistable behavior, or
the choice of individual cells between these two competing
and mutually exclusive responses is suggested to be a
stochastic process (11), the origin and mechanism of which
is still to be elucidated. A recent study by Bentele et al. (13),
on the other hand, points to the occurrence of a transition
from cell survival to cell death provided that the stimuli
exceed some threshold values. In this case, the cells exhibit
essentially a transition between two monostable regimes,
rather than two states possibly coexisting under certain
combination of stimuli as observed by Nair et al. (11).
In view of these different viewpoints, and knowing that
bistability is a functional feature in many cellular networks
(14–18), it is important to clarify if and how a mathematical
model of apoptosis can explain the occurrence of a bistable
response. Of particular interest is also to assess the con-
ditions necessary for a transition from bistable to monostable
behavior.
An insightful ﬁrst study has been performed by Eissing
et al. (19) for receptor-induced apoptosis of Type I cells.
Bistability is shown therein to result from the interference of
inhibitors of apoptosis (IAP and BAR). Our model demon-
strates the possible occurrence of bistability in mitochondria-
dependent pathways under certain conditions (see below), as
well as a transition from bistable to monostable behavior,
either apoptotic or cytoprotective, beyond threshold concen-
trations of particular components. Bistability is imparted by
kinetic cooperativity in formation of a heptameric complex
by Apaf-1 and cyt c molecules (apoptosome), after the re-
lease of cyt c from the mitochondria. The term kinetic
cooperativity refers to an effective reaction order larger than
unity in the formation of the heptameric complex from
monomers. Cooperativity (20) is assumed in the formation
of the apoptosome complex, a feature that has not been
included in previous mathematical models (13,19,21,22).
The initial apoptosis model proposed by Fussenegger et al.
(21) includes both receptor-induced and mitochondria-
dependent pathways and it is not bistable. The model
proposed by Bentele et al. (13) is not bistable and suggests a
transition from cell survival to cell death provided that the
stimuli exceed some threshold values. The model proposed
by Stucki and Simon (23) focuses on regulation of caspase-3
activation and degradation only.
In this study, we examine the response of the cell to
changes in the accessible levels of two members of the Bcl-2
family, Bax and Bcl-2, as well as the numbers of MPTPs.
Our analysis indicates that monostable cell survival is
induced if the expression (or degradation) rate of Bax is
lower (or higher) than a particular threshold, in qualitative
FIGURE 1 Mitochondria-dependent apopto-
tic pathways. The dotted region indicates the
interactions included in this model. Solid ar-
rows denote chemical reactions or upregula-
tion; those terminated by a bar denote inhibition
or downregulation; and dashed arrows describe
subcellular translocation. The following abbre-
viations are used: pro8, procaspase-8; casp8,
caspase-8; pro9, procaspase-9; casp9, caspase-9;
pro3, procaspase-3; casp3, caspase-3; ICAD,
inhibitor of caspase activated DNase; cyt c,
cytochrome c; apop, apoptosome; VAC, the
complex formed by voltage dependent anion
channel (VDAC), adenine nucleotide translo-
case (ANT), and cyclophilin D (CyP-D) at the
mitochondrial permeability transition pore.
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agreement with other studies (24). We also show that high
numbers of MPTPs may have a role in pathological cell
death (25). Parameter space searches using both reduced and
detailed mitochondria-dependent apoptosis models suggest
that cooperativity in apoptosome formation is a plausible
mechanism to ensure bistability in response to apoptotic
stimuli. The loss of bistability manifested by monostable cell
survival or cell death implicates Bax, Bcl-2, and MPTP in
pathologies like cancer and neurodegenerative disorders.
MODEL AND METHODS
Kinetic model for mitochondria-dependent
apoptotic pathways
A schematic description of the mitochondria-dependent (intrinsic) apoptotic
pathways included in our model is given in Fig. 1. The involved reactions/
interactions are summarized below, along with the corresponding rate
constants (ki) and ﬂuxes (Ji). Explicit expressions for the differential rate
equations and values of the parameters are presented in the respective Tables
1 and 2.
Cleavage of Bid by caspase-8
The cleavage of Bid to truncated Bid (tBid) by caspase-8 (casp8) (26) is
described by the following reactions, rate constants, and ﬂuxes
casp81Bid4casp8  Bid k10 ; k0 J0
casp8  Bid/casp81 tBid kf0 Jf0
(1)
Apoptosome complex formation
The apoptosome complex (apop) is a multimeric assembly composed of
seven Apaf-1 and seven cyt cmolecules (27,28). To include in our model the
cooperative nature of apoptosome formation, we adopt the reactions
cyt c1Apaf-14cytc  Apaf-1 k11 ; k1 J1
7cyt c  Apaf-14apop k11b ; k1b J1b
(2)
with the forward reaction rate of 7k1b
1[cyt cApaf-1]p for the second
reaction. A reaction order (p) higher than unity for the apoptosome complex
entails a kinetic cooperativity conducive to bistability, as will be illustrated
in the results from calculations.
Initiator caspase-9 activation
This involves ﬁve reactions; the binding of the procaspase-9 (pro9) to the
apoptosome complex, succeeded by the binding of a second pro9 to form the
complex apop(pro9)2 and the cleavage of the bound procaspases to yield
the holoenzyme apop(casp9)2, the dissociation of which ﬁnally leads to
caspases-9 (21,29), i.e.,
apop1 pro94apop  pro9 k12 ; k2 J2
apop  pro91 pro94apop  ðpro9Þ2 k13 ; k3 J3
apop  ðpro9Þ2/apop  ðcasp9Þ2 kf3 Jf3
apop  ðcasp9Þ
2
4apop  casp91 casp9 k14 ; k4 J4
apop  casp94apop1 casp9 k14b ; k4b J4b
(3)
Activation of caspase-3 by caspase-9
This is described by two reactions, the complexation of caspase-9 with the
pro3, and the succeeding cleavage of pro3 to yield the active (executioner)
caspase-3 (casp3) molecule (21), i.e.,
casp91 pro34casp9  pro3 k16 ; k6 J6
casp9  pro3/casp91 casp3 kf6 Jf6
(4)
Another mechanism of activation of caspase-3
This is the complexation of holoenzyme apop(casp9)2 with the zymogen
pro3, succeeded by the cleavage of pro3 to yield casp3 (29,30), i.e.,
apop  ðcasp9Þ
2
1pro34apop  ðcasp9Þ
2
pro3 k16b;k6b J6b
apop  ðcasp9Þ
2
pro3/apop  ðcasp9Þ
2
1casp3 kf6b J
f
6b
(5)
Inhibition of caspase-9 and -3 by IAPs
IAP inhibits both casp9 (31) and casp3 molecules by the following reac-
tions (21)
casp91IAP4casp9  IAP k15 ;k5 J5
apop casp91IAP4apop casp9  IAP k15b;k5b J5b
apop  ðcasp9Þ
2
1IAP4apop  ðcasp9Þ
2
 IAP k15c ;k5c J5c
casp31IAP4casp3  IAP k17 ;k7 J7
(6)
Cleavage of Bid by caspase-3
In addition to caspase-8 that initiates the cleavage of Bid, caspase-3 pro-
duced downstream also truncates Bid to tBid in Type II cells (26,32). The
corresponding reactions are
casp31Bid4casp3  Bid k18 ; k8 J8
casp3  Bid/casp31 tBid kf8 Jf8
(7)
The activation of Bid by casp3 completes the ﬁrst of two positive
feedback loops present in our model. The second is ensured by the cleavage
of the inhibitory protein Bcl-2 by casp3 (see ‘‘Inhibition of Bax by Bcl-2,
and cleavage (inactivation) of Bcl-2 by casp3’’ below). Upon cleavage, Bcl-
2 can no longer inhibit the channel-opening activity of Bax (8). Therefore,
casp3 indirectly enhances the formation of channels for proapoptotic cyt c
release.
Cyt c release from mitochondria to cytoplasm
In the model proposed by Fussenegger and co-workers (21), cyt c is released
when the concentration of casp3 relative to that of Bcl-2 exceeds a threshold
value. Here, we adopt a different mechanism based on experimental obser-
vations (33–36), summarized by the following sequence of events
tBid/tBidmito k11 J11
tBidmito1Bax/tBid  Bax k12a J12a
tBid  Bax1Bax/tBid1Bax2 k12b J12b
Bax21 cyt cmito/Bax21 cyt c k14 J14
(8)
Accordingly, tBid translocates to the mitochondria (k11), and forms a
complex with Bax (k12a) to initiate Bax oligomerization and channel (Bax2)
formation (k12b). Cyt c is then released through the channel (k14).
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Inhibition of Bax by Bcl-2, and cleavage (inactivation)
of Bcl-2 by casp3
The cleavage of antiapoptotic Bcl-2 by casp3 (37), which otherwise would
inhibit Bax, is described by
Bcl-21Bax/ðBcl-2  BaxÞinactive k13 J13
casp31Bcl-24casp3  Bcl-2 k19 ; k9 J9
casp3  Bcl-2/casp31Bcl-2cleaved kf9 Jf9
(9)
p53 Regulation of Bax and Bcl-2 synthesis
p53 upregulates the synthesis of Bax and downregulates that of Bcl-2
(38,39). Joers et al. (40) observed that although p53 levels increase in all
cells subject to DNA damage, only in some cells is the transcriptional
activity of p53 switched on, whereas in the remainder it is switched off. To
account for this switch-like response of p53 to DNA damage, the following
expressions are used for the rates of formation of Bax and Bcl-2.
VBcl-2 ¼ VoBcl-2½p534thresh=ð½p5341 ½p534threshÞ
VBax ¼ VoBaxð11 ½p534=ð½p5341 ½p534threshÞÞ (10)
The above two expressions closely approximate the qualitative switch-
like activity of p53. The adoption of continuous functions as opposed to
discrete threshold values permits us to perform a bifurcation analysis using
the AUTO package.
Synthesis and degradation reactions
In addition to the above sets of reactions, the model includes the synthesis
and degradation of a number of components. The proteins being synthesized
(and corresponding synthesis rates) are Apaf-1 (VApaf-1), IAP (VIAP), pro3
(Vpro3), pro9 (Vpro9), Bid (VBid), Bcl-2 (VBcl2), Bax (VBax), and cyt cmito
(Vcytmit). Recent studies show that many molecules involved in apoptotic
pathways are regulated by the ubiquitin-proteasome pathway (41). A ﬁrst-
order degradation kinetics with a uniform rate constant of m is adopted here
for casp8, casp9, casp3, pro9, pro3, Apaf-1, IAP, Bcl-2, Bid, tBid, tBidmito,
Bax, Bax2, tBidBax, cyt c, and cyt cmito. The initial concentrations of all
compounds are zero, except for pro3 and pro9, Apaf-1, Bid, Bax, Bcl-2,
IAP, and cyt cmito that are all taken as 0.004 mM because the concentrations
of proteins are usually in the nanomolar range (42), unless otherwise stated
or varied. Initial concentrations of casp8 and casp3 are indicated for each
simulation.
METHODS
The above model contains 31 components, including the
different forms of the same molecule (e.g., Bid and tBid) and
the same protein in different subcellular environments (e.g.,
cyt c in the cytosol and in the mitochondria). All interactions
(chemical or physical) are treated as chemical reactions, and
their time evolution is described by classical chemical re-
action kinetics.
We do not have conservation of the enzyme and thus do
not use Michaelis-Menten (MM) simpliﬁcation for our
reactions. We use standard mass action models from which
MM kinetics is derived when the total enzyme concentration
is constant. In all of our reactants, we maintain a small source
as well as degradation for the enzyme, such that the total
enzyme concentration is not conserved until steady-state
conditions are reached. This provides robustness to the
model, which a simple conservation model lacks. In absence
of the source and degradation, our model reduces to MM
kinetics under the pseudosteady-state hypothesis. The equa-
tions for [E] and [ES] satisfy
d½E=dt ¼ J1 Jsource  Jdecay
d½ES=dt ¼ J;
so that in the presence of the source and decay of the enzyme,
there is no longer conservation of the total enzyme and the
MM assumption is violated.
The associated set of rate equations and parameters are
listed in the respective Tables 1 and 2. Most parameters have
been assigned values within an order of magnitude of those
used in previous studies (42,43). These parameters, corre-
sponding to MAP kinase pathways, were adopted in view of
the lack of experimental data on the rate parameters of the
above-listed reactions, and experimental data have been
incorporated when available (see Table 2 footnote). With
these choices of parameters, it will be shown that the model
exhibits resistance to caspase-3 activation when p53 level is
low and and bistability to apoptotic stimuli when p53 level is
high in agreement with experiments (44). In view of the lack
of precise quantitative information on most parameters, these
results should be viewed as qualitative, rather than quanti-
tative. The coefﬁcient p was chosen to be 4. Smaller values
were also observed to lead to bistability, although the associated
threshold concentrations of caspase-3 were unrealistically
low. The simulations and bifurcation analysis have been
performed using the software XPPAUT (http://www.math.
pitt.edu/;bard/xpp/xpp.html) developed by our group at the
University of Pittsburgh, Department of Mathematics (45).
RESULTS AND DISCUSSION
First, we present the results for a few reduced models to
provide insights into the basic mechanisms that potentially
elicit a bistable response to apoptotic stimuli. We then
proceed to the analysis of a more detailed mathematical
model containing the above listed 31 components and their
interactions (Table 1).
Comparison of the robustness of possible
mechanisms of bistability using reduced models
Reduced model A: bistability induced by cooperative
formation of a component (Fig. 2 A)
We adopt ﬁrst a reduced model composed of three compo-
nents, cyt c, cyt cmito and casp3 which possesses two basic
features of the detailed model: i), a step involving cooper-
ative interaction of multiple molecules, and ii), a positive
feedback loop, expressed by the reaction scheme
2cyt c/casp3 kA1
cyt cmito1 casp3/cyt c1 casp3 k
A
2
(11)
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where kA1 and k
A
2 are corresponding rate constants. Here two
molecules of cyt c interact cooperatively to lead to caspase-3
activation; and the positive feedback loop is ensured by the
product from the second reaction (cyt c) serving as reactant
in the ﬁrst. The associated rate equations are
d½cyt c=dt ¼ 2kA1 ½cyt c21 kA2 ½casp3½cyt cmito
 mA½cyt c
d½cyt cmito=dt ¼ VAcytmit  kA2 ½casp3½cyt cmito  mA½cyt cmito
d½casp3=dt ¼ kA1 ½cyt c2  mA½casp3; (12)
where Vcytmit
A is the rate of formation of cyt cmito; m
A is the
degradation rate constant for cyt c, casp3, and cyt cmito. The
superscript denotes the reduced model A.
To test the robustness of the model, we repeated our
simulations by assigning the parameters kA1 ; k
A
2 ; V
A
cytmit; m
A
values of 0.1, 1, and 10 leading to a total of 34 ¼ 81
combinations, of which 26 exhibited a bistable behavior in
TABLE 1 The set of ordinary differential equations (ODEs) and parameters adopted in the model
d[Apaf-1]/dt ¼ J1 1 JApaf-1 d½apop  ðcasp9Þ2  pro3=dt ¼ J6b  Jf6b
d[cyt cApaf-1]/dt ¼ J1  7J1b d½casp3=dt ¼ Jf61Jf6b  J7  J81Jf8  J91Jf91Jcasp3
d[apop]/dt ¼ J1b  J2 1 J4b d½casp8=dt ¼ J01Jf01Jcasp8
d[apoppro9]/dt ¼ J2  J3 d[Bid]/dt ¼ Jo  J8 1 JBid
d[apop(pro9)2]/dt ¼ J3  J3f d½casp8  Bid=dt ¼ J0  Jf0
d½apopðcasp9Þ2=dt ¼ Jf3  J4  J5c  J6b1Jf6b d[Bcl-2]/dt ¼ J9  J13 1 JBcl2
d[apopcasp9]/dt ¼ J4 1 J4b  J5b d½casp3  Bid=dt ¼ J8  Jf8
d½casp9=dt ¼ J4  J4b  J5  J61Jf61Jcasp9 d½casp3  Bcl 2=dt ¼ J9  Jf9
d[pro9]/dt ¼ J2  J3 1 Jpro9 d[Bax]/dt ¼ J12a  J12b  J13 1 JBax
d[IAP]/dt ¼ J5  J5b  J5c  J7 1 JIAP d½tBid=dt ¼ Jfo1Jf8  J111J12b1JtBid
d[casp9IAP]/dt ¼ J5 d[tBidBax]/dt ¼ J12a  J12b 1 JtBidBax
d[apopcasp9IAP]/dt ¼ J5b d[cyt cmito]/dt ¼ J14 1 Jcytmit
d[apop(casp9)2IAP]/dt ¼ J5c d[Bax2]/dt ¼ J12b 1 JBax2
d[casp3IAP]/dt ¼ J7 d[tBidmito]/dt ¼ J11  J12a 1 JtBidmit
d[pro3]/dt ¼ J6  J6b 1 Jpro3 d[cyt c]/dt ¼ J14  J1 1 Jcytc
d½casp9pro3=dt ¼ J6  Jf6
with
Reaction rates (or ﬂuxes) Production-degradation rates
J09 ¼ k10 ½casp8½Bid  k0 ½casp8  Bid JApaf-1 ¼ VApaf-1  m[Apaf-1]
Jf0 ¼ kf0½casp8  Bid JIAP ¼ VIAP  m[IAP]
J1 ¼ k11 ½cyt c½Apaf-1  k1 ½cyt c  Apaf-1 Jpro3 ¼ Vpro3  m[pro3]
J1b ¼ k11b½cyt c  Apaf-1p  k1b½apop Jpro9 ¼ Vpro9  m[pro9]
J2 ¼ k12 ½apop½pro9  k2 ½apop  pro9 JBid ¼ VBid  m[Bid]
J3 ¼ k13 ½apop  pro9½pro9  k3½apop  ðpro9Þ2 JBcl2 ¼ VBcl2  mBcl2[Bcl-2]
Jf3 ¼ kf3½apop  ðpro9Þ2 JBax ¼ VBax  mBax[Bax]
J4 ¼ k14 ½apop  ðcasp9Þ2  k4 ½apop  casp9½casp9 Jcytmit ¼ Vcytmit  m[cyt cmito]
J4b ¼ k14b½apop  casp9  k4b½apop½casp9 Jcasp9 ¼ m[casp9]
J5 ¼ k15 ½casp9½IAP  k5 ½casp9  IAP Jcasp3 ¼ m[casp3]
J5b ¼ k15b½apop  casp9½IAP  k5b½apop  casp9  IAP JtBid ¼ m[tBid]
J5c ¼ k15c½apop  ðcasp9Þ2½IAP  k5c½apop  ðcasp9Þ2  IAP JtBidBax ¼ m[tBidBax]
J6 ¼ k16 ½casp9½pro3  k6 ½casp9  pro3 JBax2 ¼ m[Bax2]
Jf6 ¼ kf6½casp9  pro3 JtBidmit ¼ m[tBidmito]
J6b ¼ k16b½apop  ðcasp9Þ2½pro3  k6b½apop  ðcasp9Þ2  pro3 Jcytc ¼ m[cyt c]
Jf6b ¼ kf6b½apop  ðcasp9Þ2  pro3 Jcasp8 ¼ m[casp8]
J7 ¼ k17 ½casp3½IAP  k7 ½casp3  IAP
J8 ¼ k18 ½casp3½Bid  k8 ½casp3  Bid
Jf8 ¼ kf8½casp3  Bid
J9 ¼ k19 ½casp3½Bcl2  k9 ½casp3  Bcl2
Jf9 ¼ kf9½casp3  Bcl2
J11 ¼ k11[tBid]
J12a ¼ k12a[tBidmito][Bax]
J12b ¼ k12b[tBidBax][Bax]
J13 ¼ k13[Bcl2][Bax]
J14 ¼ k14[Bax2][cyt cmito]
FIGURE 2 Reduced models of apoptosis (A) in the presence of cooper-
ative interactions and positive feedback loop; (B) in the presence of positive
feedback but absence of cooperative interactions; and (C) with inhibition of
caspase-3 by IAP, in the absence of cooperativity.
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response to apoptotic stimuli. The initial concentration of
casp3 serves here as the apoptotic stimulus.
Reduced model B with positive feedback loop by no
cooperativity in any component formation (Fig. 2 B)
The following interactions deﬁne this model
cyt c/casp3 kB1
cyt cmito1 casp3/cyt c1 casp3 k
B
2
(13)
With the corresponding rate equations
d½cyt c=dt ¼ kB1 ½cyt c1 kB2 ½casp3½cyt cmito  mB½cyt c
d½cyt cmito=dt ¼ VBcytmit  kB2 ½casp3½cyt cmito  mB½cyt cmito
d½casp3=dt ¼ kB1 ½cyt c  mB½casp3: (14)
We repeated our calculations for the same set of 81
choices of parameters. None of the simulations led to a
bistable response, indicating that the kinetic scheme in Fig. 2
B, is not likely to lead to bistability.
Reduced model C: inhibition by IAP (Fig. 2 C)
In this model, cyt c release induces casp3 activation without
cooperativity. Two more reactions are included to account
for the inhibition of apoptosis by IAP. This reduced model
has mechanisms comparable to those described by Eissing
and co-workers (19). It essentially contains a feedback loop
and takes into consideration the inhibition of casp3 by IAP
via formation of a complex casp3.IAP by the following
reaction scheme
cyt c/casp3 kC1
cyt cmito1 casp3/cyt c1 casp3 k
C
2
casp31 IAP/casp3:IAP kC3
casp3:IAP/casp31 IAP kC3
(15)
The associated rate equations are
d½cytc=dt¼kC1 ½cytc1kC2 ½casp3½cytcmitomC½cytc
d½cytcmito=dt¼VCcytmitkC2 ½casp3½cytcmitomC½cytcmito
d½casp3=dt¼kC1 ½cytckC3 ½casp3½IAP
1kC3½casp3:IAPmC½casp3
d½IAP=dt¼VCIAPkC3 ½casp3½IAP1kC3½casp3:IAP
mCIAP½IAP
d½casp3:IAP=dt¼ kC3 ½casp3½IAPkC3½casp3:IAP
mCcasp3IAP½casp3:IAP: (16)
The parameters kC1 ; k
C
2 ; V
C
cytmit; m
C were again assigned
values of 0.1, 1, 10, and k C3 is taken as k
C
3 =10, giving rise to
34 ¼ 81 simulations. To account for the two new interac-
tions, we assigned to the new parameters (VCIAP; m
C
IAP; k
C
3 )
one at a time, the same discrete values, whereas holding the
other two equal to 1, which leads to a total of 81 3 9 com-
binations. Only three out of all these combinations exhibited
a bistable response, whereas in all other cases, a monostable
cell survival or apoptosis has been observed.
Reduced model D: inhibition by IAP with cooperativity similar
to the model by Stucki and Simon (23)
In this reduced model, we explored if some other type
of cooperativity could be effective for ensuring bistability.
We assumed the degradation of caspase-3 by IAP to be
modulated allosterically as proposed by Stucki and Simon
(23). The same interactions and rate equations as those used
in the reduced model C are adopted here, except for the
inclusion of an additional term for caspase-3 degradation in
which we use the expression and coefﬁcients (including the
Hill coefﬁcient 4) proposed by Stucki and Simon (23). The
differential rate equation for the time evolution of caspase-3
becomes
d½casp3=dt¼kD1 ½cytckD3 ½casp3½IAP1kD3½casp3:IAP
5½casp3½casp3:IAP4=ð241 ½casp3:IAPÞ4
mD½casp3: (17)
The same set of simulations as those described above for
the reduced model C were repeated to end up with the same
number (3) of combinations leading to bistability. However,
we noted that the steady-state concentration of caspase-3 was
lower for this reduced model.
The above analysis demonstrates that a pathway that
involves a positive feedback loop with cooperative interac-
tions (reduced model A) is more likely to elicit a bistable
response, among the different cases investigated. Also, it is
seen that kinetic cooperativity is not the only possible
mechanism for inducing bistability, and does not always
imply cooperativity. We now proceed to the illustration of
the validity of the same mechanism in our detailed model
that contains both features, described in detail in the Model
and Methods section.
Cooperativity in apoptosome formation ensures
bistability in detailed model
Any stimulus that produces caspase-8 may initiate mito-
chondria-dependent apoptotic interactions (Fig. 1). Caspase-
8 truncates Bid to tBid, which results in the activation of
caspase-3 by a cascade of reactions after the translocation of
tBid to mitochondria. The activation of caspase-3 gives rise
to two positive feedback loops (Eqs. 7 and 9) that amplify the
response to the initial triggering effect of caspase-8. Our
model does not include the pathways upstream of caspase-8
activation. We assume that a transient proapoptotic stimu-
lation results in production of caspase-8 in proportion to the
exposure of the cell to death signal ligands. Here the
coefﬁcient p involved in the formation of apoptosome (Eq. 2)
is taken as p¼ 4. Although pmight be as large as seven for a
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fully cooperative formation of a heptameric structure, a value
of four was observed to be sufﬁcient to ensure bistability,
whereas lower p-values would necessitate unrealistic (pico-
molar) concentrations of caspase-3 to elicit a bistable response.
Fig. 3, A and B, illustrate two opposite behaviors observed
in response to small changes in proapoptotic stimuli
(represented here by the initial caspase-8 concentration)
provided that the apoptotic pathways involve a cooperative
step. When the original caspase-8 level is relatively low,
[casp8]0 ¼ 105 mM, for example, cell survival is observed
as a monostable response (Fig. 3 A) using the differential rate
equations and parameters listed in the respective Tables 1 and
2. Cell survival is manifested therein by a decrease in the
concentration of executioner caspase-3 to negligibly small
values. On the other hand, the opposite behavior, i.e., mono-
stable PCD, is induced (Fig. 3 B) if the proapoptotic stimulus
exceeds a threshold level (see below). In Fig. 3 B the concen-
tration of casp3 is shown to increase by two orders of magni-
tude, to 4.5 3 103 mM, from the same initial concentration
(105 mM) as in Fig. 3 A. The only difference in panel B as
compared to panel A is the increase (104 mM) in the initial
concentration of the proapoptotic stimulus ([casp8]0).
We note that the model is not restricted to apoptosis
caused by extracellular stimuli exclusively. The PCD in
panel B was veriﬁed to also occur with a zero initial caspase-
8 concentration and nonzero initial caspase-3 concentration
(e.g., [casp3]0 ¼ 5 3 104 mM, which eventually leads to
[casp3] ¼ 4.8 3 103 mM; data not shown). Therefore,
apoptosis may be equally driven by intrinsic proapoptotic
stimuli that induce caspase-3 activation. In our analysis,
caspase-3 steady-state concentrations of the order of nano-
molars were accepted to lead to apoptosis, whereas cell
survival would refer to vanishingly small concentrations.
Finally, in the absence of cooperativity (p ¼ 1), the same
initial conditions for caspase-8 and caspase-3 that led to cell
survival in Fig. 3 A, are now observed to induce apoptosis, as
implied by the high concentrations (63 103 mM) caspase-3
reaches at steady state (Fig. 3 C). This is an example of
pathological cell death rather than a normal response to small
apoptotic stimuli (cell survival/protection). The system does
not exhibit a bistable behavior in response to variations in
[casp8]0. Instead, apoptosis is the only stable state, despite
the low original concentration of caspase-8.
Taken together, these results suggest that the cooperativity
in apoptosome formation, might be a mechanism in cells to
ensure healthy functioning of cells to apoptotic stimuli, in-
stead of invariably leading to apoptosis in response to min-
imal stimulation.
Biological signiﬁcance of the bistable model:
roles of Bax, Bcl-2, and MPTP in pathological PCD
Bax degradation and expression rates can determine the
transition between bistable and monostable responses
Apoptosis can be controlled by the degradation rate of
proapoptotic proteins such as Bax (46). We examined if our
mathematical model conﬁrms this behavior. Fig. 4 A depicts
the bifurcation diagram as a function of the degradation rate
(mBax) of Bax and the initial concentration of caspase-3. The
limit point for saddle-node bifurcation is found as mBax ¼
0.11 s1 using the parameters listed in Table 2. Below this
limit point, there exist three steady states, two of which are
stable and one unstable. Therefore, the system is bistable in
this regime. Conversely, above the limit point, there is only
one stable state, i.e., the system is monostable. The arrows in
Fig. 4 A, indicate the direction of evolution of casp3 levels,
starting from any region of the diagram (i.e., any combina-
tion of the two parameters). The solid curve represents the
stable apoptosis loci achieved with casp3 concentrations
above the dotted curve, and the lower solid line represents
the stable cell survival state, characterized by zero casp3
concentration. The dashed curve represents the loci of unsta-
ble steady state leading to either cell death or cell survival,
FIGURE 3 Time evolution of caspase-3 in response to minor changes in initial caspase-8 concentration [casp8]0. (A) Cell survival when [casp8]0 is small
(105 mM), indicated by the decrease in the caspase-3 concentration (initially 105 mM) to zero at steady state; (B) apoptosis, implied by the increase
in caspase-3 concentration to a high value (4.5 3 103 mM) at steady state despite the same initial value of caspase-3 as in panel A, when [casp8]0 is higher
(104 mM); (C) monostable apoptosis, in the absence of cooperativity (p ¼ 1) using the same initial concentrations of caspase-3 and caspase-8 as in panel A.
Here caspase-3 concentration reaches a high value (6 3 103 mM) at long times indicative of apoptotic response. Note that the ordinate scales are different
in the panels.
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upon slight perturbation. It also deﬁnes the threshold con-
centration of apoptotic stimuli (casp3) to trigger apoptosis as
a function of the degradation rate of Bax. In the monostable
regime, even very high initial casp3 concentrations decay to
zero. Therefore, when the rate of degradation of Bax is
higher than the limit point, apoptosis cannot occur, regard-
less of caspase levels.
Fig. 4 B illustrates the time evolution toward monostable
cell survival. With mBax ¼ 0.2 s1 (higher than the limit
point), the concentration of casp3 decays from [casp3]0 ¼
0.1 mM to zero, even when [casp8]0 is also high (0.1 mM).
Notably, our results are in accord with those of Li and Dou,
who demonstrated that elevated Bax degradation is a sur-
vival mechanism in human cancer cells (46).
Fig. 4 C is the bifurcation diagram for rate of formation of
Bax. The limit point for the saddle-node bifurcation is
VoBax ¼ 6:033106 mM=s. Above this point, a bistable
behavior is predicted in response to proapoptotic stimuli.
FIGURE 4 Effect of degradation rate of Bax (mBax) on cell behavior. (A)
Bifurcation diagram for mBax. Limit point for saddle-node bifurcation is
mBax ¼ 0.11 s1. Below this limit point, there are three steady states, two of
which are stable and one unstable; above the limit point, there is only one
stable state, cell survival. The arrows indicate the equilibrium concentrations
reached when starting from any point in the diagram; (B) the high initial
concentration of caspase-3 (0.1 mM) decreases to zero when mBax is in the
monostable cell survival region (0.2 s1) despite the high [casp8]0 value; (C)
bifurcation diagram forVoBax. Limit point for saddle-node bifurcation is 6.03
3 106 mM/s. The stable cell survival line ([casp3]o ¼ 0) is not shown
because the y axis is logarithmic.
TABLE 2 The model parameters*
Rate constants Other parameters
k10 ¼ 10mM1s1 k0 ¼ 0:5 s1
kf0 ¼ 0:1 s1 k11 ¼ 5mM1s1 p ¼ 4
k1 ¼ 0:5 s1 k11b ¼ 53104mM3s1 [p53thresh] ¼ 0.004 mM
k1b ¼ 0:5 s1 k12 ¼ 10mM1s1 m ¼ 0.006 s1
k2 ¼ 0:5 s1 k13 ¼ 10mM1s1 VApaf-1 ¼ 3 3 104 mM/s
k3 ¼ 0:5 s1 kf3 ¼ 0:1 s1 VIAP ¼ 3 3 105 mM/s
k14 ¼ 5mM1s1 k4 ¼ 0:5 s1 Vpro3 ¼ 3 3 104 mM/s
k14b ¼ 5mM1s1 k4b ¼ 0:5s1 Vpro9 ¼ 3 3 104 mM/s
k15 ¼ 5mM1s1 k5 ¼ 0:0035 s1 VBid ¼ 3 3 105 mM/s
k15b ¼ 5mM1s1 k5b ¼ 0:0035 s1 VoBcl2 ¼ 83105 mM=s
k15c ¼ 5mM1s1 k5c ¼ 0:0035 s1 VoBax ¼ 33105 mM=s
k16 ¼ 10mM1s1 k6 ¼ 0:5 s1 Vcytmit ¼ 3 3 104 mM/s
kf6 ¼ 0:001 s1 k16b ¼ 10mM1s1 [p53] ¼ 0.0066 mM
k6b ¼ 0:5 s1 kf6b ¼ 0:1 s1
k17 ¼ 5mM1s1 k7 ¼ 0:0035 s1
k18 ¼ 10mM1s1 k8 ¼ 0:5 s1
kf8 ¼ 0:1 s1 k19 ¼ 10mM1s1
k9 ¼ 0:5 s1 kf9 ¼ 0:1 s1
k11 ¼ 10 s1 k12a ¼ 10 mM1s1
k12b ¼ 10 mM1s1 k13 ¼ 10 mM1s1
k14 ¼ 10 mM1s1
*All rate constants, except for k7 ; k

5 ; k

5b; k

5c; k
1
1b; k11; k12a; k12b; k13;
k14; ½p53thresh, are set up to within one order of magnitude difference with
respect to those used by Asthagiri and Lauffenburger (43) in their
simulations of mitogen-activated protein kinase pathways. The ratio of
k17 =k

7 ensures an equilibrium constant of 0.7 nM (56), as well as those
used for deﬁning k5 ; k

5b; and k

5c. The values of k
1
1b; k11; k12a; k12b; k13;
k14; ½p53thresh are suitably set to achieve ﬂuxes comparable to other
compounds’ ﬂuxes; kf6 is assigned a value smaller than k
f
6b because of
experimental observations by Riedl et al. (30). The degradation constant of
all species is assigned as 0.006 s1 unless speciﬁed otherwise in the text.
This value is within the range of parameters used for degradation rate con-
stants adopted by Chen et al. (42) The rates of synthesis are within the range
of values used by Chen et al. (42).
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For VoBax,6:03310
6 mM=s, on the other hand, the
response is monostable cell survival, even in the presence
of high apoptotic stimuli. This result is consistent with
observations of decreased Bax expression in human breast
cancers (47).
This model thus predicts that cells will exhibit a
monostable cell survival response to apoptotic stimuli if
the degradation rate of Bax is above some threshold value or
if the expression rate of Bax is below some threshold value
(shown in the respective panels A and C of Fig. 4) In this
monostable regime, the caspase-3 concentration always
diminishes to zero because there is not a sufﬁciently high
concentration of Bax to open up channels on mitochondrial
membrane for releasing cyt c. The net result is that the
activation rate of caspase-3 becomes lower than its degra-
dation rate, eventually leading to vanishingly low concen-
trations of caspase-3. In the bistable regime, on the other
hand, a dichotomous response favoring either cell survival
(vanishingly small casp3 concentration) or programmed cell
death (casp3 above nanomolar concentration) is elicited,
depending on the original casp3 concentrations. Overall, the
model predicts that there exists a critical point at which the
amount of Bax leads to monostable cell survival that might
be associated with the onset of cancer in living cells.
Bcl-2 counteracts the effect of Bax
Bcl-2 is the classical, antiapoptotic member of the Bcl-2
family. Danial and Korsmeyer state in their recent review
(48) that the ratio of Bcl-2/Bax constitutes a rheostat that sets
the threshold of susceptibility to apoptosis for the mitochon-
dria-dependent pathway. Accordingly, we tested if our
mathematical model would demonstrate a counteracting
role of Bcl-2 vis-a`-vis the effects of Bax. We illustrate the
effect of Bcl-2 on the proapoptotic effects of Bax in Fig. 5 A.
The series of curves in this ﬁgure represent the bifurcation
diagrams as a function of the degradation rate of Bax for
different expression rates of Bcl-2. Fig. 5 B displays the
results as a function of the synthesis rate of Bax. Therefore,
Fig. 5, A and B, are the counterparts of the respective Fig. 4,
A and C, obtained for different rates of formation of Bcl-2.
The increase in the rate of formation of Bcl-2, VoBcl2, is
observed to have several effects (Fig. 5 A). First, the limit
point for the saddle-node bifurcation decreased to lower Bax
degradation rates. When VoBcl2 ¼ 83105 mM=s, the limit
point was mBax ¼ 0.11 s1 (Fig. 4 A). This result is included
in Fig. 5 A for comparative purposes. The limit point de-
creased to mBax ¼ 0.085 s1 for VoBcl2 ¼ 3:23104 mM=s,
and to mBax ¼ 0.042 s1 for VoBcl2 ¼ 83104 mM=s.
Hence, the bistable cell survival region, which may possibly
give rise to apoptosis becomes narrower, whereas the mono-
stable cell survival region becomes broader, when Bcl-2 is
overexpressed. This result is consistent with the observation
that Bcl-2 is overexpressed in many types of tumors that
exhibit low rates of apoptosis (49). Second, the threshold
concentration of casp3 for undergoing apoptosis with a given
Bax degradation rate mBax, tends to increase with increase in
Bcl-2 expression rate, as indicated by the vertical shifting of
the dashed portions of the curves in Fig. 5 A. This result
implies that larger or more potent proapoptotic stimuli are
needed for PCD when Bcl-2 expression levels are relatively
high. Third, the apoptotic concentration of casp3 for given
degradation rates of Bax (i.e., the solid portions of the bifur-
cation curves) are lowered with increasing Bcl-2 expression
rates.
In Fig. 5 B, we observe the equilibrium caspase-3
concentrations as a function of Bax expression rate, VoBax,
again for various rates of formation of Bcl-2,VoBcl2. First, the
limit point for the saddle-node bifurcation shifts to higher
VoBax values with increasing V
o
Bcl2. The limit point of
VoBax ¼ 6:033106 mM=s (also shown in Fig. 4 C) is shifted
to 1.17 3 105 mM/s, and then to 2.16 3 105 mM/s as
VoBcl2 increases from 8 3 10
5 mM/s to 3.2 3 104 mM/s,
and then to 8 3 104 mM/s. Hence, the bistable region
becomes narrower and the monostable cell survival region,
broader, when Bcl-2 expression levels increase. Second, the
threshold [casp3]0 for entering apoptosis shift to higher
values in the bistable regions. Third, the steady-state con-
centrations of casp3 in the case of apoptosis slightly shift to
lower values, similarly to their counterparts in Fig. 5 A.
These results suggest that the proapoptotic effect of a low
rate of Bax degradation or high rate of Bax expression can be
FIGURE 5 Effects of Bcl-2 expres-
sion rate on cell behavior in response to
changes in Bax levels. (A) Effect on the
bifurcation diagram for mBax; (B) effect
on the bifurcation diagram for VoBax.
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counteracted by high rate of Bcl-2 expression, and is in
keeping with the known interaction of these proteins (48).
High Bcl-2 oncogene expression can sensitize the cells to
cancer. Conversely, downregulation of Bcl-2 can sensitize
melanoma cells to apoptosis (50,51). In a broader sense, the
relative production and degradation rates of Bax and Bcl-2
determine whether the cell will survive or undergo apoptosis
(48), consistent with our analysis.
Effect of MPTP on the detailed mitochondria-dependent
apoptosis model
The mechanisms of cyt c release from mitochondria are
highly diverse and controversial (52,53). In this model, we
assume that cyt c release is closely dependent on the
formation/activation of MPTPs (25,54) irrespective of Bax
channel formation on mitochondria. The nonspeciﬁc MPTP
involved in cyt c release is proposed to be a complex formed
by the proteins VDAC-ANT-CyP-D (54). We denote this
nonspeciﬁc pore by (VAC) here. The release of cyt c from
the nonspeciﬁc pore, cyt cmito 1 VAC / cyt c, with rate
constant of 1mM1s1 is included in the model to account for
this dependence.
The bifurcation diagram in Fig. 6 illustrates the effect of
VAC level on the steady-state concentration of caspase-3. In
these calculations, the p53 concentration was assigned a
relatively low value (0.0022 mM) so that the response to
apoptotic stimulus (here [casp3]0) would be monostable cell
survival in the absence of VAC. At low levels of VAC (,2.3
3 104 mM), the system exhibits a monostable cell survival.
At intermediate VAC levels (2.3 3 104 mM , [VAC] ,
9.0 3 104 mM), a bistable behavior is observed, in accord
with the healthy functioning of cells. At VAC levels above
the limit point of 9.0 3 104 mM, apoptosis is induced,
which may be pathological in some cases (25).
Robustness of cooperative apoptosome formation as a
mechanism that imparts bistability
Inhibition of caspases (19) was proposed previously as a
mechanism that can lead to bistability. Our study of the
robustness of different possible mechanisms using different
reduced models (Fig. 2) indicated that the reduced model
A, containing a positive feedback loop and a cooperative
interaction, had a much higher propensity to exhibit a
bistable behavior than the other three models. We conducted
a similar computation for the detailed model proposed for
mitochondria-dependent apoptosis. We mainly compared
the robustness of two different mechanisms in inducing
bistability: inhibition of caspase-3 by IAP and cooperative
formation of apoptosome. To this aim, we organized the
parameters into 13 groups and varied them within an order of
magnitude, which led to 213 ¼ 8192 parameter sets. In the
absence of cooperativity (i.e., when the coefﬁcient p was set
equal to unity), none of the 8192 simulations led to a bistable
response to apoptotic stimuli despite the IAP inhibition of
caspase-3. In the presence of cooperativity, or when p was as-
signed the respective values of 2 and 3, we observed that 320
and 736 of the runs resulted in a bistable response, support-
ing the importance of cooperative apoptosome formation for
inducing bistability over a wide range of parameters.
Comparison with experiments
Inhibition of Bax degradation induces apoptosis in Bcl-2
overexpressing cells
Li and Dou (46) studied the effect of a proteasome inhib-
itor, N-carbobenzoxy-L-leucyl-norvalinal (LLnV), on Bcl-2
overexpressing Jurkat T cells that are protected from
apoptosis. LLnV was shown to induce caspase-mediated
apoptosis after cyt c release. It was also shown that LLnV
inhibited Bax degradation in a cell-free assay. These ﬁndings
are consistent with a role for the ubiquitin-proteasome path-
way in regulating key players in the apoptotic cascade (41).
To test this conjecture, we carried out the following
simulations. First, we examined the response of Bcl-2-
overexpressing cells to apoptotic stimuli in the absence of a
proteasome inhibitor.We assigned the values ofmBax¼ 0.1 s1
and VoBcl2 ¼ 3:23104 mM=s, which result in monostable
cell survival as the Bax degradation rate is higher than the limit
point (0.085 s1) (SeeFig. 5A). The curvewith the solid circles
in Fig. 7, A and B, displays the time evolution of cyt c and
caspase-3, respectively, under these conditions. Both curves
show the depression of apoptotic molecules to negligibly low
concentrations, suggesting the occurrence of monostable cell
survival under these conditions. Second, we simulated the time
evolution of the same Bcl-2-overexpressing cells in the
presence of proteasome inhibitor, by linearly decreasing mBax
to 0.04 s1 in 1200 s, and maintaining this rate constant
thereafter. The initial concentrations for both casp8 and pro3
were assigned to be 0.1 mM. This simulation resulted in an
FIGURE 6 Bifurcation diagram as a function of the concentration of
mitochondrial permeability pore complex [VAC]. The limit points for
saddle-node bifurcation are at [VAC]¼2.33 104 mM and 9.03 104 mM.
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increase in cyt c release and an increase in casp3 level (curves
with open circles in panels A and B of Fig. 7). The qualitative
agreement between simulations and experiments suggests that
the onset of cancer may be associated with a Bax degradation
rate higher than a certain threshold value (the limit point in the
bifurcation diagram shown in Fig. 5 A).
Simulating the effect of silymarin on apoptosis
In a recent study by Katiyar et al. (44), it was shown that
silymarin, a plant ﬂavonoid that is known to inhibit skin
carcinogenesis in mice, induced caspase-3 activation in JB6
C141 cells (preneoplastic epidermal keratinocytes). The
concentration of silymarin is shown therein to be correlated
with p53 concentrations, suggesting that silymarin acts via
increasing the p53 levels.
To explore if our model could explain/interpret the
experimental data collected by Katiyar et al., we performed
a mathematical analysis of the effect of changes in p53. We
varied p53 concentration from a low value (0.0022 mM)
characteristic of monostable cell survival, to higher values in
accord with the relative increases reported in Fig. 3 of
Katiyar et al. (44). The selected [p53]0 values and resulting
caspase-3 concentrations are shown in panel A of Fig. 8. The
accompanying changes in the relative levels of Bax, Bcl-2,
and cyt c are displayed in the respective panels B–D of the
same ﬁgure. The comparison of the computational results
(solid bars) with those from experiments (44), shown by the
crisscrossed bars, shows that there is a good qualitative
agreement between the two sets, except for Bcl-2 concen-
trations at relatively high p53 levels, which seem to deplete
faster in computations than in experiments. This discrepancy
may be due to the adoption of Eq. 10 for describing the time
evolution of Bcl-2 (and Bax) expression levels as a function
of p53 concentration. The threshold p53 concentration for
inducing transcriptional activity refers to a relative increase
in [p53]0 of approximately two (abscissa in Fig. 8), and the
computed abrupt decrease in Bcl-2 may be attributed to this
change in regime. Additionally, experiments show the
average behavior of an ensemble of cells (with a distribution
of p53 concentrations), which would be expected to lead to a
smoother change in [Bcl-2] compared to that predicted by
computations.
CONCLUSION
In this study, the cooperative formation of heptameric
apoptosome complex is proposed to be an important
mechanism for the bistable behavior (survival or apoptosis)
of cells in response to apoptotic stimuli of extracellular or
intracellular origin. We examined the effects of Bax, Bcl-2,
and MPTP levels on the time evolution of mitochondria-
dependent apoptotic events, and show that there are subtle
changes from monostable to bistable response, which may
also be counteracted, depending on the relative concentra-
tions of these components. We concentrated on two positive
feedback loops in particular, which are suggested to play an
important role in ensuring bistability (14–16,18,55). The
former is initiated by the cleavage/inhibition of Bcl-2, and
the latter by the truncation of Bid to tBid, both by the
executioner caspase-3.
Several conclusions with possible biomedical implications
are inferred from this analysis:
There are critical values for the synthesis or degradation of
Bax beyond which cells would exhibit a monostable
cell survival. This result is in accord with observations
suggesting that human prostate cancer cells might use
Bax degradation as a survival mechanism (46). Our
results are also consistent with the observed decreases
in Bax expression levels in primary human breast
tumors (47).
Bcl-2 can counteract the proapoptotic effect of Bax to result
in monostable cell survival, in line with the over-
expression of Bcl-2 in many types of tumors (49) and
the known role of Bcl-2 in countering the effects of
Bax (48).
The extent of MPTP may result in a diversity of responses,
ranging from monostable cell survival, to bistable
behavior, or monostable apoptosis. As shown in Fig. 6,
an increase in [VAC] converts monostable cell survival
response into a bistable response. The ﬁgure also
FIGURE 7 Time evolution of (A)
cyt c; (B) caspase-3 levels with (open
circles) and without (solid circles)
inhibition of Bax degradation. Inhibi-
tion of Bax degradation induces an
accumulation in cyt c and caspase-3
levels.
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shows that high [VAC] can lead to pathological cell
death, in accord with the role of MPTPs in pathological
cell death suggested by Green and Kroemer (25).
The inhibition of Bax degradation can induce apoptosis.
This result is in agreement with the observation of Li
and Dou (46).
Our model predictions are in quantitative agreement with the
experimental data reported by Katiyar et al. (44) where
p53 was induced by silymarin to induce casp3. The
concentrations of cyt c and Bax are shown in both
analyses to increase with the increases in p53 levels,
whereas that of Bcl-2 would decrease.
Taken together, our results suggest that there might be a
transition from bistable to monostable behavior in response
to proapoptotic stimuli. The changes in synthesis and deg-
radation rates of Bax and Bcl-2 and in the number of MPTPs
may have a role in leading to aberrant phenotypes such as
cancer and neurodegenerative disorders (2).
Previous mathematical models proposed for apoptosis
(13,19,21–23) differ from this study in: i), the choice of apo-
ptotic pathways, ii), their mathematical methods and param-
eters, and iii), the network properties focused on. With regard
to apoptotic pathways, the model by Fussenegger et al. (21)
and Bentele et al. (13) included both receptor-dependent
(extrinsic) and receptor-independent (mitochondria-dependent)
pathways. Eissing et al. (19) focused on receptor-dependent
pathways observed in Type-I cells, Stucki and Simon (23)
concentrated on pathways that regulate casp3, and Siehs et al.
(22) focused on the interactions of Bcl-2 family members
and consequent cyt c release. In terms of method of ap-
proach, Siehs et al. (22) simulated the time evolution of Bcl-2
family molecules using discrete time and space variables in a
lattice molecular automaton. A systematical approach has
been performed by Bentele et al. (13), not only to determine
the parameters from experiments, but also to unravel the
most important interactions by a rigorous sensitivity analy-
sis. Fussenegger et al. (21) pioneered the mathematical mod-
eling of apoptosis. However, this model would invariably
progress toward apoptosis, containing no antiapoptotic mech-
anisms for cells. More recent models (13,19,22,23) including
this study, point to the requirement of a homeostatic balance
between the two responses, manifested by a bistable
behavior or a switch from one response to another under
well-deﬁned conditions.
We examined mitochondria-dependent pathways here,
which are connected to receptor-dependent pathways
through cleavage of Bid by caspase-8, only. Our work
differs from that of others in that caspase inhibition is not
necessarily the only mechanism that leads to bistability.
Instead, cooperativity in apoptosome formation is demon-
strated to play an important role. This model is the ﬁrst
bistable model for mitochondria-dependent apoptosis, and
suggests plausible roles for Bax, Bcl-2, and MPTP in
pathologies such as cancer and diseases characterized by
FIGURE 8 Comparison of the experimental and theoretical changes in
caspase-3, Bax, Bcl-2, cyt c, in response to the relative changes in p53 (that
are induced by changes in the ﬂavanoid silymarin concentrations). Panel A
displays the caspase-3 levels corresponding to each selected [p53] computed
by present simulations. Panels B–D display the results from computations
(solid bars) and those from experiments (criss-crossed bars).
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excessive apoptosis, which will need to be further estab-
lished by experiments.
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